Cofoe Medical Technology (01187) received 8 million A-shares pledged by controlling shareholder Xiezi Hao Investment.

Cofoe Medical Technology (01187) announced that on September 23, 2026, the Company was informed that its controlling shareholder, Changsha Xiezi Hao Medical Investment Co., Ltd. (Xiezi Hao Investment), on September 22, 2026, pledged 8 million A-shares of the Company (approximately 3.39% of the Company's total issued share capital) held by it in favor of Agricultural Bank of China Limited, Changsha Yuhua District Sub-branch (the pledgee, an authorized institution as defined under the Banking Ordinance (Chapter 155 of the Laws of Hong Kong)), as security for its bona fide commercial loan. To the best of the Company's Directors' knowledge, the pledgee is an independent third party of the Company and is not a connected person of the Company. As at the date of this announcement, Xiezi Hao Investment has pledged a total of 16 million A-shares of the Company held by it (approximately 6.78% of the Company's total issued share capital). The shares of the Company held by Xiezi Hao Investment are not subject to any freezing, and as at the date of this announcement, Xiezi Hao Investment has good credit standing and corresponding repayment ability. The pledged shares are not subject to the risk of forced liquidation or compulsory transfer, and the pledge risk is controllable. When the pledged shares are at risk of forced liquidation, Xiezi Hao Investment will promptly notify the Company and will strictly comply with the relevant regulations to fulfill its information disclosure obligations.